Minerva Neurosciences Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Minerva Neurosciences Inc
TickerNERV
CIK #0001598646
CUSIP603380205
SectorLife Sciences - Pharmaceutical Preparations
Address245 First Street Suite 1800, Cambridge, MA 02142
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Minerva Neurosciences Inc 2023-07-03 Exemption: 506(b) · Remaining: $19,999,994 · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001598646] 10-K
[0001598646] 10-Q
[0001598646] 3
[0001598646] 4
[0001598646] 5
[0001598646] 8-K
[0001598646] D
[0001598646] SC 13D
[0001598646] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Janus Henderson Group PLC Minerva Neurosciences Inc [2026-05-15] 0.0
Coastlands Capital LP Minerva Neurosciences Inc [2026-02-20] 0.0
Logos Global Management LP Minerva Neurosciences Inc [2026-02-17] 0.0
Balyasny Asset Management LP Minerva Neurosciences Inc [2026-02-17] 0.0
Adage Capital Management LP Minerva Neurosciences Inc [2026-02-12] 0.0
Vivo Opportunity Fund Holdings LP Minerva Neurosciences Inc [2025-12-31] 0.0
Farallon Capital Partners LP Minerva Neurosciences Inc [2025-12-29] 0.0
Federated Hermes Inc Minerva Neurosciences Inc [2025-12-29] 0.0
Federated Hermes Inc Minerva Neurosciences Inc [2025-10-28] 0.0
FMR LLC Minerva Neurosciences Inc [2024-02-09] 0.0
Boehringer AG Minerva Neurosciences Inc [2023-07-07] 20.79
Point72 Asset Management LP Minerva Neurosciences Inc [2022-08-23] 8.8
Assenagon Asset Management Sa Minerva Neurosciences Inc [2021-11-24] 14.23
Assenagon Asset Management Sa Minerva Neurosciences Inc [2021-11-24] 3.24
Vanguard Group Inc Minerva Neurosciences Inc [2021-02-10] 9.96
Luthringer Remy Minerva Neurosciences Inc [2019-02-14] 5.9
BlackRock Inc Minerva Neurosciences Inc [2019-02-08] 6.3
BlackRock Inc Minerva Neurosciences Inc [2018-02-01] 5.2
Highland Capital Management Fund Advisors LP Minerva Neurosciences Inc [2016-02-11] 9.4
Federated Investors Inc /PA/ Minerva Neurosciences Inc [2015-04-09] 18.19
Cormorant Global Healthcare Master Fund LP Minerva Neurosciences Inc [2015-03-23] 7.2
FMR LLC Minerva Neurosciences Inc [2015-02-13] 0.0
Care Capital III LLC Minerva Neurosciences Inc [2014-07-18] 21.2
Index Venture Associates III Ltd Minerva Neurosciences Inc [2014-07-18] 15.4
Johnson & Johnson Minerva Neurosciences Inc [2014-07-17] 18.0
Luthringer Remy Minerva Neurosciences Inc [2014-07-17] 7.0
Form 3/4/5 Filer 2011 - 2026
Kupfer David
Minerva Neurosciences Inc
van Heek G Jan
Hasler Hans Peter
Kaul Inderjit
Ahlholm Frederick W
Luthringer Remy
Laghrissi-Thode Fouzia
O'Connor James Joseph
Race Geoff
Hilleman Jeryl L
Boehringer Ingelheim International GmbH
Boehringer AG
Barclays PLC
Doyle William F
Reilly Joseph H
Smith Devin Whittemore
Saoud Jay
Davidson Michael
Russell Richard E
Index Venture Associates IV Ltd
Yucca Jersey SLP
Index Venture Associates V Ltd
Index Venture Associates III Ltd
Beer Marc D
Johnson & Johnson
Johnson & Johnson Development Corp ET AL
Vandervelpen Nico
Levine Mark S
Ollier Michele
de Rubertis Francesco
Care Capital Offshore Investments III LP
Care Capital III LLC
Care Capital Investments III LP
Pellegrini Lorenzo
Vivaldi Coelho Rogerio
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Kaul Inderjit
Stock Option (right to buy) · derivative
2025-12-22 Grant 364,504 $0.00
Hasler Hans Peter
Stock Option (right to buy) · derivative
2025-12-22 Grant 50,000 $0.00
Kupfer David
Stock Option (right to buy) · derivative
2025-12-22 Grant 50,000 $0.00
Laghrissi-Thode Fouzia
Stock Option (right to buy) · derivative
2025-12-22 Grant 50,000 $0.00
van Heek G Jan
Stock Option (right to buy) · derivative
2025-12-22 Grant 50,000 $0.00
Ahlholm Frederick W
Employee Stock Option (right to buy) · derivative
2025-12-22 Grant 500,000 $0.00
Race Geoff
Employee Stock Option (right to buy) · derivative
2025-12-22 Grant 1,500,000 $0.00
Luthringer Remy
Employee Stock Option (right to buy) · derivative
2025-12-22 Grant 2,250,000 $0.00
Kaul Inderjit
Stock Option (right to buy) · derivative
2025-11-14 Grant 9,500 $0.00
van Heek G Jan
Stock Option (right to buy) · derivative
2024-12-05 Grant 12,500 $0.00
Laghrissi-Thode Fouzia
Stock Option (right to buy) · derivative
2024-12-05 Grant 12,500 $0.00
Kupfer David
Stock Option (right to buy) · derivative
2024-12-05 Grant 12,500 $0.00
Hasler Hans Peter
Stock Option (right to buy) · derivative
2024-12-05 Grant 12,500 $0.00
Ahlholm Frederick W
Employee Stock Option (right to buy) · derivative
2024-12-05 Grant 47,500 $0.00
Race Geoff
Employee Stock Option (right to buy) · derivative
2024-12-05 Grant 95,000 $0.00
Luthringer Remy
Employee Stock Option (right to buy) · derivative
2024-12-05 Grant 105,000 $0.00
Luthringer Remy
Employee Stock Option (right to buy) · derivative
2023-10-04 Grant 100,450 $0.00
Race Geoff
Employee Stock Option (right to buy) · derivative
2023-10-04 Grant 87,050 $0.00
Ahlholm Frederick W
Employee Stock Option (right to buy) · derivative
2023-10-04 Grant 42,850 $0.00
van Heek G Jan
Stock Option (right to buy) · derivative
2023-09-27 Grant 12,500 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 47 38,298,188
2025-12-31 33 23,072,824
2025-09-30 25 1,979,787
2025-06-30 23 1,944,682
2025-03-31 23 1,952,081
2024-12-31 24 2,085,909
2024-09-30 23 2,118,041
2024-06-30 22 2,086,314
2024-03-31 22 2,121,296
2023-12-31 21 2,421,780
2023-09-30 21 2,403,063
2023-06-30 20 2,352,312
Form 13F Holdings
Firm Period DFND Voting Shares
Y-Intercept Hong Kong Ltd [2026-06-30] SOLE 64,687 64,687
Apella Capital LLC [2026-06-30] SOLE 0 42,250
Fortitude Family Office LLC [2026-06-30] SOLE 303 303
Farther Finance Advisors LLC [2026-06-30] SOLE 0 100
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com